"Novel Fungal Probiotics Show Promise in Improving Gut Health and Reducing Long COVID Symptoms"
Two specific strains of fungi, Cyberlindnera jadinii and Kluyveromyces lactis, commonly used in food production, have shown positive probiotic effects on gut inflammation in a mouse model. The study, published in mSystems, highlights the potential of these fungi in treating inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease. However, further research is needed before applying these findings to human clinical settings. Probiotics, including bacterial strains, are known to support gut health, and while the role of fungi in gut microbiome is understudied, this research opens up new possibilities for understanding the impact of fungi on gut health.
